Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

549 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Beta-blocker treatment of chronic systolic heart failure improves prognosis even in patients meeting one or more exclusion criteria of the MERIT-HF study.
Jost A, Rauch B, Hochadel M, Winkler R, Schneider S, Jacobs M, Kilkowski C, Kilkowski A, Lorenz H, Muth K, Zugck C, Remppis A, Haass M, Senges J; HELUMA study group. Jost A, et al. Among authors: senges j. Eur Heart J. 2005 Dec;26(24):2689-97. doi: 10.1093/eurheartj/ehi473. Epub 2005 Sep 23. Eur Heart J. 2005. PMID: 16183697
Clinical benefit of early reperfusion therapy in patients with ST-elevation myocardial infarction usually excluded from randomized clinical trials (results from the Maximal Individual Therapy in Acute Myocardial Infarction Plus [MITRA Plus] registry).
Koeth O, Zahn R, Gitt AK, Bauer T, Juenger C, Senges J, Zeymer U; Maximal Individual Therapy in Acute Myocardial Infarction Plus Study Group. Koeth O, et al. Among authors: senges j. Am J Cardiol. 2009 Oct 15;104(8):1074-7. doi: 10.1016/j.amjcard.2009.05.054. Am J Cardiol. 2009. PMID: 19801027
549 results